Overview

Tech Summary

Promoter Holding

Posts

STAR

501234567890012345678920123456789.3012345678950123456789
+15.70 (+3.23%)
The current prices are delayed.Login/Sign Upto see live prices.
Previous Close: 486.65
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
489
Today's high
505.9
52 week low
268.15
52 week high
549
Volume
833660
About
TECHNICAL SUMMARY
DMA(12)
₹336.3
DMA(50)
₹322.35
DMA(100)
₹330.27
DMA(200)
₹330.98
FUNDEMANTAL SUMMARY
Market Cap
₹4536.22 Cr.
Enterprise Value
₹6994.72 Cr.
No. of Shares
9.03
P/E
0
RoE
-10.15
Debt/Equity
1.27
Valuations
PE CHART
200400600800
PB CHART
1.21.41.61.82.0
Promoter Holdings
Public : 35.21%
FII : 16.67%
DII : 20.05%
Promoter : 28.07%
Others : 0%
Charts
DEBT/EQUITY
0.800.901.001.101.20
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE VS ROCE
-15-10-50510
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE
ROCE
REVENUE VS PROFITABILITY (1000CR.)
0.01.02.03.04.0
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Revenue
Profit
MARGINS(%)
-1001020
Mar, 2019Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Net Margin
Gross Margin
Posts by FrontPage Users
S
Reputation: 44  •  Yesterday 5:20 AM

#STAR buy at 485 add till 455 with SL of 435. Target 10/15/20%
Chartbusters - chart - 232650479

Vote

Comment
Share
Add a comment
Himanshu Trading Zone-display-image
Reputation: 26,345  •  Nov 24 1:35 PM

BUY STAR ABOVE 500.75 SL 484.95 T1 531.10 T2 569.70
Chartbusters - chart - 227589043

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 21 5:18 PM
Strides Pharma rallies after seizure drug receives US FDA approval
Strides Pharma rallies after seizure drug receives US FDA approval
The company's wholly owned step-down subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval.
Moneycontrol

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Strides Pharma Science Limited's subsidiary has received USFDA approval for its seizures drug, Levetiracetam Oral Solution.
• The product has a market size of ~US$55 Mn and will be manufactured at the company's facility in Bengaluru.
• Strides Pharma has......read more

Vote

Comment
Share
Add a comment
Dhananjay-display-image
Reputation: 27,843  •  Nov 21 5:16 PM

Vote

Comment
Share
Add a comment
Himanshu Trading Zone-display-image
Reputation: 26,345  •  Nov 6 1:44 PM

SELL STAR BELOW 478.40 SL 493.05 T1 453.65 T2 414.40
Chartbusters - chart - 211822042

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Nov 1 2:34 PM

𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Strides Pharma reported a 11.41% increase in net sales in September 2023 compared to the same period in 2022.
• The company also saw a significant decrease in net loss, down 675.43% from the previous year.
• EBITDA also showed a strong growth of 55.42% i......read more

Vote

Comment
Share
Add a comment
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 30 8:03 PM
Strides Pharma Science Q2 loss at Rs 149 crore
Strides Pharma Science Q2 loss at Rs 149 crore
The drug firm had reported a net profit of Rs 19 crore for the year-ago period.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 27 11:43 PM
Strides Pharma to sell its Singapore manufacturing facility for $15 million
Strides Pharma to sell its Singapore manufacturing facility for $15 million
Additionally, as part of the transaction, Rxilient Biohub will assume the long-term lease obligation associated with the manufacturing site from Strides
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 6 5:08 PM
Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%
Strides Pharma Science shares worth Rs 69 crore exchange hands; stock falls over 1.5%
13.75 lakh shares of Strides Pharma Sciences changed hands, following which, the stock price sank over 1.5 percent
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 5 3:23 PM
Strides Pharma Science trades marginally lower despite USFDA nod
Strides Pharma Science trades marginally lower despite USFDA nod
The company has received approval for Efavirenz (600mg), Emtricitabine (200mg), Tenofovir Disproxil Fumurate (300mg), (EET) tablets from the United States Food & Drug Administration (USFDA).
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 4 9:56 PM
Strides Pharma gets USFDA nod to market HIV drug
Strides Pharma gets USFDA nod to market HIV drug
The company's product is bioequivalent and therapeutically equivalent to Atripla Tablets of Gilead Sciences LLC, it added. As per per IQVIA, Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumurate tablet (EET) has a market opportunity of USD 7.5 million in the US.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Oct 3 10:01 PM
Strides Pharma Science gets USFDA nod for generic capsule to control triglyceride level
Strides Pharma Science gets USFDA nod for generic capsule to control triglyceride level
The product is bioequivalent and therapeutically equivalent to the reference listed drug Vascepa of Amarin. It will be manufactured at the company's facility in Bengaluru, it added. The Icosapent Ethyl capsules have a market size of around USD 1.3 billion, Strides said, citing IQVIA.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 28 3:28 AM
Reduce Strides Pharma Science; target of Rs 495: ICICI Securities
Reduce Strides Pharma Science; target of Rs 495: ICICI Securities
ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 27 7:58 PM
Hold Strides Pharma Science; target of Rs 600: Sharekhan
Hold Strides Pharma Science; target of Rs 600: Sharekhan
Sharekhan recommended Hold rating on Strides Pharma Science with a target price of Rs 600 in its research report dated September 26, 2023.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 27 3:51 PM
Reduce Strides Pharma Science, target price Rs 495:  ICICI Securities
Reduce Strides Pharma Science, target price Rs 495: ICICI Securities
Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 4766.18 Crore) operating in Pharmaceuticals sector.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 26 5:51 PM
Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businesses
Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businesses
As per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. The consensus recommendation from 3 analysts for the stock is a 'Buy'.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 25 10:58 PM
Strides Pharma to spin off CDMO, soft gelatin biz into OneSource; listing expected in 12 months
Strides Pharma to spin off CDMO, soft gelatin biz into OneSource; listing expected in 12 months
Demerger will be completed by April 1, 2024 according to the stock exchange filing
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 25 10:41 PM
Strides Pharma announces business rejig. Shares end 7% up, hit 52 week high
Strides Pharma announces business rejig. Shares end 7% up, hit 52 week high
The announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday's closing price. Strides Pharma Science shares also hit their 52-week high of Rs 539.
The Economic Times

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 25 3:03 PM
Strides Pharma trades 2% up after USFDA nod for drug to reduce heart issues
Strides Pharma trades 2% up after USFDA nod for drug to reduce heart issues
The company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with USFDA, of which 230+ ANDAs have been approved.
Moneycontrol

Vote

Comment
Share
Add a comment
Manish-display-image
Reputation: 96  •  Sep 19 1:34 AM

Plan the Trade, Trade the plan
Stop loss = 326
Take profit 1 = 450
Take profit 2 = 550
Chartbusters - chart - 167641348

1 Vote

2 Comments
Share
Add a comment
Brijrajsinh Jadeja-display-image
Reputation: 80  •  Sep 18 4:25 AM

#STAR #swingtrade #study date 17.09.2023 After ATH breakout stock may undergo some retracement and then have a potential to give a big up move. May see 550 and above targets in few weeks.
Chartbusters - chart - 166171277

Vote

Comment
Share
Add a comment
Rajesh-display-image
Reputation: 128  •  Sep 15 8:04 PM

#STAR near weekly pattern breakout if break then good for swing trade. For education purpose only.
Chartbusters - chart - 165864471

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 15 3:28 PM
Strides Pharma up 4% as arm receives tentative USFDA approval for Dolutegravir tablets
Strides Pharma up 4% as arm receives tentative USFDA approval for Dolutegravir tablets
The products will be manufactured at the company’s facility in Bengaluru and conversion of this tentative approval to a full approval is expected upon expiry of the constraining patents.
Moneycontrol

2 Votes

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 15 2:01 AM
Strides Pharma arm gets USFDA tentative nod for generic HIV treatment drug
Strides Pharma arm gets USFDA tentative nod for generic HIV treatment drug
Strides Pharma Global, a subsidiary of Strides Pharma Science, has received tentative approval from the US FDA for its generic Dolutegravir tablets used in HIV treatment. The approval allows the company to participate in global donor-funded programs that procure the medicine.
The Economic Times

Vote

Comment
Share
Add a comment
Dhananjay-display-image
Reputation: 27,843  •  Sep 8 3:51 PM

2 Votes

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Sep 7 5:03 PM
Strides Pharma gains 6% as board gives nod to acquire 100% in Strides Pharma Services
Strides Pharma gains 6% as board gives nod to acquire 100% in Strides Pharma Services
The said transaction is to be completed by September 15, 2023.
Moneycontrol

Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 30 7:23 PM
Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral suspension
Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral suspension
The approval granted by the US Food & Drug Administration (USFDA) is for Mycophenolate Mofetil for oral suspension of strength 200 mg/ml, Strides Pharma Science said in a regulatory filing.
Moneycontrol

3 Votes

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 30 7:11 PM
Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral suspension
Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral suspension
Strides Pharma Science Ltd on Wednesday said its wholly-owned arm, Strides Pharma Global Pte. Ltd, Singapore, has received approval from the US health regulator for generic Mycophenolate Mofetil for oral suspension indicated in organ transplant patients to avoid rejection. The approval granted by the US Food & Drug Administration (USFDA) is for Mycophenolate Mofetil for oral suspension of strength 200 mg/ml, Strides Pharma Science said in a regulatory filing.
The Economic Times

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Aug 6 4:43 PM
Hold Strides Pharma Sciences; target of Rs 491: Sharekhan
Hold Strides Pharma Sciences; target of Rs 491: Sharekhan
Sharekhan recommended Hold rating on Strides Pharma Sciences with a target price of Rs 491 in its research report dated August 02, 2023.
Moneycontrol

1 Vote

Comment
Share
Add a comment
Add a comment
Add a comment
K
Reputation: 384  •  Aug 2 4:57 AM

#STAR pharma should be close above 487.20 level tomorrow, results will come🤑🤑🤑🤑🤑
Chartbusters - chart - 119303810

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Jul 5 7:43 PM
Strides Pharma sinks after subsidiary plans to divest manufacturing plant
Strides Pharma sinks after subsidiary plans to divest manufacturing plant
The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity.
Moneycontrol

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Jul 5 6:41 AM
Strides sells arm's manufacturing unit to Syngene International for Rs 702 crore
Strides sells arm's manufacturing unit to Syngene International for Rs 702 crore
Strides Pharma Science has agreed to sell the biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma to Syngene International for INR702 crore ($94m) in cash. Syngene will also invest up to INR100 crore to repurpose and revalidate the Bommasandra Industrial Area in Bengaluru site, which is being repurposed to produce monoclonal antibodies.
The Economic Times

1 Vote

Comment
Share
Add a comment
NewsBot-display-image
Reputation: 181,377  •  Jul 1 6:01 PM
Screaming Buy! 400 midcap & smallcap stocks give double-digit returns in June
Screaming Buy! 400 midcap & smallcap stocks give double-digit returns in June
Indian equities, including the Nifty50 and Sensex, experienced gains for the fourth consecutive month in June. While the benchmark indices returned nearly 3% for the month, the midcap and smallcap segments were the top performers, with about 400 stocks delivering double-digit returns. Sectors such as automobiles, healthcare, and information technology saw strong buying interest, and experts recommend long-term investors to continue accumulating quality stocks while being cautious of profit booking. The upcoming Q1-FY24 results are expected to provide further fuel to the market rally.
The Economic Times

2 Votes

Comment
Share
Add a comment
Load More Posts
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Stock Sentiments
95% Bullish
5% Bearish
44 live trades of Rs. 3,871,847.05
S
sandy-S1AQkLXLi
 
Reputation: 0 • 
Today 8:55 PM
STAR
250 Qty (S) Trade entered-₹75
P
prysm
 
Reputation: 0 • 
Today 8:55 PM
STAR
100 Qty (S) Trade entered-₹15